Segment Information (Tables)

6 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization, were as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(Dollars in thousands)	2020			2019			2020			2019
Revenue:
Medical Device	$	16,304		$	17,301		$	33,708		$	34,559
In Vitro Diagnostics		6,518			5,375			11,730			10,358
Total revenue	$	22,822		$	22,676		$	45,438		$	44,917
Operating (loss) income:
Medical Device	$	(1,453	)	$	(23	)	$	(1,876	)	$	334
In Vitro Diagnostics		3,462			2,915			6,061			5,370
Total segment operating income		2,009			2,892			4,185			5,704
Corporate		(2,165	)		(2,027	)		(4,607	)		(4,127	)
Total operating (loss) income	$	(156	)	$	865		$	(422	)	$	1,577
Depreciation and amortization:
Medical Device	$	1,439		$	1,447		$	2,894		$	2,835
In Vitro Diagnostics		109			117			219			233
Corporate		248			255			487			507
Total depreciation and amortization	$	1,796		$	1,819		$	3,600		$	3,575